Format
Sort by

Send to

Choose Destination

Search results

Items: 6

1.

Cybrid models of Parkinson's disease show variable mitochondrial biogenesis and genotype-respiration relationships.

Keeney PM, Dunham LD, Quigley CK, Morton SL, Bergquist KE, Bennett JP Jr.

Exp Neurol. 2009 Dec;220(2):374-82. doi: 10.1016/j.expneurol.2009.09.025.

2.
3.

Recombinant mitochondrial transcription factor A with N-terminal mitochondrial transduction domain increases respiration and mitochondrial gene expression.

Iyer S, Thomas RR, Portell FR, Dunham LD, Quigley CK, Bennett JP Jr.

Mitochondrion. 2009 Jun;9(3):196-203. doi: 10.1016/j.mito.2009.01.012.

4.

Mitochondrial gene therapy augments mitochondrial physiology in a Parkinson's disease cell model.

Keeney PM, Quigley CK, Dunham LD, Papageorge CM, Iyer S, Thomas RR, Schwarz KM, Trimmer PA, Khan SM, Portell FR, Bergquist KE, Bennett JP Jr.

Hum Gene Ther. 2009 Aug;20(8):897-907. doi: 10.1089/hum.2009.023.

5.

Relationships among molecular genetic and respiratory properties of Parkinson's disease cybrid cells show similarities to Parkinson's brain tissues.

Borland MK, Mohanakumar KP, Rubinstein JD, Keeney PM, Xie J, Capaldi R, Dunham LD, Trimmer PA, Bennett JP Jr.

Biochim Biophys Acta. 2009 Jan;1792(1):68-74. doi: 10.1016/j.bbadis.2008.09.014.

6.

National Practitioner Data Bank: implications for hospital administrators and care review professionals.

Micheletti JA, Dunham LD.

J Qual Assur. 1990 Apr-Jun;12(2):18-23. No abstract available.

PMID:
10104852
Items per page

Supplemental Content

Loading ...
Support Center